Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This study aims to determine whether early treatment with zoledronic acid, that is given
during the early phase of advanced prostate cancer, will be more efficacious than delayed
treatment